Cargando…

NPM1 upregulates the transcription of PD-L1 and suppresses T cell activity in triple-negative breast cancer

Programmed cell death protein-1 (PD-1)/programmed cell death ligand-1 (PD-L1) interaction plays a crucial role in tumor-associated immune escape. Here, we verify that triple-negative breast cancer (TNBC) has higher PD-L1 expression than other subtypes. We then discover that nucleophosmin (NPM1) bind...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qin, Ge, Wang, Xin, Ye, Shubiao, Li, Yizhuo, Chen, Miao, Wang, Shusen, Qin, Tao, Zhang, Changlin, Li, Yixin, Long, Qian, Hu, Huabin, Shi, Dingbo, Li, Jiaping, Zhang, Kai, Zhai, Qinglian, Tang, Yanlai, Kang, Tiebang, Lan, Ping, Xie, Fangyun, Lu, Jianjun, Deng, Wuguo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7125142/ https://www.ncbi.nlm.nih.gov/pubmed/32245950 http://dx.doi.org/10.1038/s41467-020-15364-z

Ejemplares similares

CPSF4 promotes triple negative breast cancer metastasis by upregulating MDM4
por: Lee, Kaping, et al.
Publicado: (2021)

Poly(U) binding splicing factor 60 promotes renal cell carcinoma growth by transcriptionally upregulating telomerase reverse transcriptase
por: Long, Qian, et al.
Publicado: (2020)

Palbociclib inhibits epithelial-mesenchymal transition and metastasis in breast cancer via c-Jun/COX-2 signaling pathway
por: Qin, Ge, et al.
Publicado: (2015)

Melatonin inhibits AP-2β/hTERT, NF-κB/COX-2 and Akt/ERK and activates caspase/Cyto C signaling to enhance the antitumor activity of berberine in lung cancer cells
por: Lu, Jian-Jun, et al.
Publicado: (2015)

RBFOX3 Promotes Tumor Growth and Progression via hTERT Signaling and Predicts a Poor Prognosis in Hepatocellular Carcinoma
por: Liu, Tianze, et al.
Publicado: (2017)

KMT2A regulates cervical cancer cell growth through targeting VDAC1
por: Zhang, Changlin, et al.
Publicado: (2020)

Berberine Targets AP-2/hTERT, NF-κB/COX-2, HIF-1α/VEGF and Cytochrome-c/Caspase Signaling to Suppress Human Cancer Cell Growth
por: Fu, Lingyi, et al.
Publicado: (2013)

RPS3 regulates melanoma cell growth and apoptosis by targeting Cyto C/Ca(2+)/MICU1 dependent mitochondrial signaling
por: Tian, Yun, et al.
Publicado: (2015)

Quercetin Suppresses Cyclooxygenase-2 Expression and Angiogenesis through Inactivation of P300 Signaling
por: Xiao, Xiangsheng, et al.
Publicado: (2011)

Friend Leukemia Virus Integration 1 Expression Has Prognostic Significance in Nasopharyngeal Carcinoma()
por: Liang, Xuexia, et al.
Publicado: (2014)

Upregulation of Cleavage and Polyadenylation Specific Factor 4 in Lung Adenocarcinoma and Its Critical Role for Cancer Cell Survival and Proliferation
por: Chen, Wangbing, et al.
Publicado: (2013)

Activating enhancer-binding protein-2α induces cyclooxygenase-2 expression and promotes nasopharyngeal carcinoma growth
por: Shi, Dingbo, et al.
Publicado: (2014)

Targeting PDK1 with dichloroacetophenone to inhibit acute myeloid leukemia (AML) cell growth
por: Qin, Lijun, et al.
Publicado: (2015)

Determining the contribution of NPM1 heterozygosity to NPM-ALK-induced lymphomagenesis
por: McDuff, Fiona Kate Elizabeth, et al.
Publicado: (2011)

Nicotine Promotes Proliferation of Human Nasopharyngeal Carcinoma Cells by Regulating α7AChR, ERK, HIF-1α and VEGF/PEDF Signaling
por: Shi, Dingbo, et al.
Publicado: (2012)

MAD2L2 inhibits colorectal cancer growth by promoting NCOA3 ubiquitination and degradation
por: Li, Yixin, et al.
Publicado: (2018)

TFAP2B overexpression contributes to tumor growth and a poor prognosis of human lung adenocarcinoma through modulation of ERK and VEGF/PEDF signaling
por: Fu, Lingyi, et al.
Publicado: (2014)

Immortalization-upregulated protein promotes pancreatic cancer progression by regulating NPM1/FHL1-mediated cell-cycle-checkpoint protein activity
por: Luo, Qiankun, et al.
Publicado: (2022)

NPM1 histone chaperone is upregulated in glioblastoma to promote cell survival and maintain nucleolar shape
por: Holmberg Olausson, Karl, et al.
Publicado: (2015)

Construction and validation of a macrophage polarization-related prognostic index to predict the overall survival in patients with early-stage triple-negative breast cancer
por: Luo, Hanjia, et al.
Publicado: (2023)

Ku80 promotes melanoma growth and regulates antitumor effect of melatonin by targeting HIF1-α dependent PDK-1 signaling pathway
por: Liu, Tianze, et al.
Publicado: (2019)

Bone Marrow Clonogenic Myeloid Progenitors from NPM1-Mutated AML Patients Do Not Harbor the NPM1 Mutation: Implication for the Cell-Of-Origin of NPM1+ AML
por: Diaz de la Guardia, Rafael, et al.
Publicado: (2020)

Nucleophosmin1 (NPM1) abnormality in hematologic malignancies, and therapeutic targeting of mutant NPM1 in acute myeloid leukemia
por: Chen, Yingyu, et al.
Publicado: (2020)

NPM and NPM-MLF1 interact with chromatin remodeling complexes and influence their recruitment to specific genes
por: Darracq, Anaïs, et al.
Publicado: (2019)

The Impact of Mutation of Myelodysplasia-Related Genes in De Novo Acute Myeloid Leukemia Carrying NPM1 Mutation †
por: Wang, Yi, et al.
Publicado: (2022)

Function of homo- and hetero-oligomers of human nucleoplasmin/nucleophosmin family proteins NPM1, NPM2 and NPM3 during sperm chromatin remodeling
por: Okuwaki, Mitsuru, et al.
Publicado: (2012)

Clinical genomic profiling to identify actionable alterations for very early relapsed triple-negative breast cancer patients in the Chinese population
por: Wang, Liye, et al.
Publicado: (2021)

Effective Menin inhibitor-based combinations against AML with MLL rearrangement or NPM1 mutation (NPM1c)
por: Fiskus, Warren, et al.
Publicado: (2022)

NPM1 alternative transcripts are upregulated in acute myeloid and lymphoblastic leukemia and their expression level affects patient outcome
por: Handschuh, Luiza, et al.
Publicado: (2018)

Significance of NPM1 Gene Mutations in AML
por: Hindley, Andrew, et al.
Publicado: (2021)

The antagonistic duality of NPM1 mutations in AML
por: Khan, Irum, et al.
Publicado: (2022)

NPM 1 Mutations in AML—The Landscape in 2023
por: Sharma, Naman, et al.
Publicado: (2023)

FLI1 regulates radiotherapy resistance in nasopharyngeal carcinoma through TIE1-mediated PI3K/AKT signaling pathway
por: Chen, Enni, et al.
Publicado: (2023)

The absent/low expression of CD34 in NPM1-mutated AML is not related to cytoplasmic dislocation of NPM1 mutant protein
por: Pianigiani, Giulia, et al.
Publicado: (2022)

Causal linkage of presence of mutant NPM1 to efficacy of novel therapeutic agents against AML cells with mutant NPM1
por: Mill, Christopher P., et al.
Publicado: (2023)

Characterization and dynamics of specific T cells against nucleophosmin-1 (NPM1)-mutated peptides in patients with NPM1-mutated acute myeloid leukemia
por: Forghieri, Fabio, et al.
Publicado: (2019)

Tumor stromal type is associated with stromal PD-L1 expression and predicts outcomes in breast cancer
por: Zhai, Qinglian, et al.
Publicado: (2019)

Targeting NPM1 in irradiated cells inhibits NPM1 binding to RAD51, RAD51 foci formation and radiosensitizes NSCLC
por: Traver, Geri, et al.
Publicado: (2020)

Melatonin enhances sorafenib-induced cytotoxicity in FLT3-ITD acute myeloid leukemia cells by redox modification
por: Tian, Tian, et al.
Publicado: (2019)

Knockdown of NPM1 by RNA Interference Inhibits Cells Proliferation and Induces Apoptosis in Leukemic Cell Line
por: Qin, Feng-Xian, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_i09h0delpgnpn868su3sorasrm